BMO Capital Markets Reiterates “Hold” Rating for Genpact Limited (G)

Genpact Limited (NYSE:G)‘s stock had its “hold” rating reissued by equities research analysts at BMO Capital Markets in a report released on Friday.

G has been the subject of a number of other research reports. Zacks Investment Research lowered shares of Genpact Limited from a “hold” rating to a “sell” rating in a report on Friday, July 28th. Cantor Fitzgerald reissued a “buy” rating and set a $32.00 target price on shares of Genpact Limited in a research report on Wednesday, September 13th. Cowen and Company reissued an “outperform” rating and set a $33.00 target price (up previously from $30.00) on shares of Genpact Limited in a research report on Thursday, August 3rd. Deutsche Bank AG increased their target price on shares of Genpact Limited from $26.00 to $28.00 and gave the company a “hold” rating in a research report on Thursday, August 3rd. Finally, Robert W. Baird reissued a “buy” rating and set a $34.00 target price on shares of Genpact Limited in a research report on Monday, September 25th. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $31.86.

Shares of Genpact Limited (NYSE:G) opened at 29.14 on Friday. The firm has a market cap of $5.62 billion, a PE ratio of 22.01 and a beta of 0.53. Genpact Limited has a 12 month low of $22.62 and a 12 month high of $31.93. The stock’s 50 day moving average is $28.44 and its 200 day moving average is $27.09.

Genpact Limited (NYSE:G) last issued its quarterly earnings data on Wednesday, August 2nd. The business services provider reported $0.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.31 by $0.10. The business had revenue of $670.70 million during the quarter, compared to analyst estimates of $642.68 million. Genpact Limited had a net margin of 10.22% and a return on equity of 23.33%. The firm’s quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter last year, the business earned $0.36 EPS. Analysts forecast that Genpact Limited will post $1.56 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This article was originally published by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this article on another site, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this article can be viewed at https://transcriptdaily.com/2017/10/08/bmo-capital-markets-reiterates-hold-rating-for-genpact-limited-g.html.

In other news, major shareholder Bain Capital Investors Llc sold 8,498,874 shares of the firm’s stock in a transaction that occurred on Friday, August 18th. The shares were sold at an average price of $28.72, for a total transaction of $244,087,661.28. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Mohit Thukral sold 25,000 shares of the firm’s stock in a transaction that occurred on Friday, August 25th. The stock was sold at an average price of $28.37, for a total transaction of $709,250.00. Following the sale, the insider now directly owns 85,305 shares of the company’s stock, valued at approximately $2,420,102.85. The disclosure for this sale can be found here. Insiders have sold a total of 10,358,442 shares of company stock valued at $297,475,276 in the last three months. Insiders own 1.55% of the company’s stock.

Hedge funds have recently made changes to their positions in the company. YorkBridge Wealth Partners LLC grew its position in shares of Genpact Limited by 5.2% during the 2nd quarter. YorkBridge Wealth Partners LLC now owns 3,793 shares of the business services provider’s stock worth $106,000 after buying an additional 189 shares during the period. Acrospire Investment Management LLC grew its position in shares of Genpact Limited by 569.8% during the 2nd quarter. Acrospire Investment Management LLC now owns 4,019 shares of the business services provider’s stock worth $112,000 after buying an additional 3,419 shares during the period. SG Americas Securities LLC acquired a new stake in shares of Genpact Limited during the 1st quarter worth approximately $110,000. Bronfman E.L. Rothschild L.P. grew its position in shares of Genpact Limited by 1.9% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 5,053 shares of the business services provider’s stock worth $141,000 after buying an additional 94 shares during the period. Finally, BNP Paribas Arbitrage SA grew its position in shares of Genpact Limited by 85.3% during the 1st quarter. BNP Paribas Arbitrage SA now owns 5,220 shares of the business services provider’s stock worth $129,000 after buying an additional 2,403 shares during the period. 92.16% of the stock is owned by institutional investors.

Genpact Limited Company Profile

Genpact Limited is engaged in providing digitally powered business process management and services. The Company is also engaged in designing, transforming and running a combination of processes, as well as providing solutions that combine elements of its service offerings. The Company’s segments include Business process outsourcing and Information technology services.

Analyst Recommendations for Genpact Limited (NYSE:G)

Receive News & Ratings for Genpact Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact Limited and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply